IL-21-STAT3 axis negatively regulates LAIR1 expression in B cells

Area of Science:

• Immunology
• Cell Biology
• Autoimmunity

Background:

• Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) is an inhibitory receptor on immune cells, including B cells.
• LAIR1's role in regulating B cell autoreactivity and its expression patterns during B cell differentiation are not fully understood.

Purpose of the Study:

• To investigate the expression profile of LAIR1 on human B cells.
• To determine LAIR1's regulatory function in B cell autoreactivity.
• To explore the relationship between LAIR1 expression and B cell differentiation, particularly in the context of systemic lupus erythematosus (SLE).

Main Methods:

• Analysis of LAIR1 expression levels on human B cells across differentiation stages.
• Comparison of transcriptional profiles and in vitro differentiation potential between LAIR1-expressing and LAIR1-negative B cells.
• Investigation of the IL-21/STAT3 pathway's role in LAIR1 downregulation.

Main Results:

• LAIR1 expression decreases during B cell differentiation.
• LAIR1-expressing switched memory B cells exhibit less differentiation toward plasma cells and harbor more autoreactive B cells compared to LAIR1-negative counterparts.
• Patients with SLE show reduced LAIR1 expression on B cells, associated with enhanced plasma cell differentiation.
• IL-21/STAT3 pathway downregulates LAIR1 expression.

Conclusions:

• LAIR1 functions as a critical checkpoint for maintaining B cell tolerance.
• Breakdown of the LAIR1 checkpoint contributes to autoreactivity and aberrant plasma cell differentiation in SLE.
• Targeting the IL-21/STAT3 pathway may offer therapeutic strategies for SLE by restoring LAIR1 expression and reducing aberrant B cell activity.